Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytoreductive Nephrectomy”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Post-approval studies (Phase 4)Looking for participantsNCT06903312
What this trial is testing

Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.

Who this might be right for
Renal Cell CancerKidney NeoplasmImmunotherapy+3 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 409
Not applicableNot Yet RecruitingNCT07233668
What this trial is testing

Immediate Versus Deferred Cytoreductive Nephrectomy With Ipilimumab/Nivolumab in mRCC

Who this might be right for
Metastatic Renal Cell Carcinoma ( mRCC)
Seoul National University Hospital 172
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07816770
What this trial is testing

MANTIS-RCC: Toripalimab-Axitinib Induction in TLS-Positive Advanced Non-Clear Cell and Renal Medullary Carcinomas

Who this might be right for
Metastatic Non-Clear Cell Renal Cell CarcinomaMetastatic Renal Medullary Carcinomas
Fudan University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06279403
What this trial is testing

Upfront Immune Checkpoint Inhibitors With Deferred Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma

Who this might be right for
Clear-cell Metastatic Renal Cell CarcinomaImmune Checkpoint InhibitorsCytoreductive Nephrectomy
RenJi Hospital 20
Not applicableStudy completedNCT01982097
What this trial is testing

Sorafenib as Neoadjuvant Therapy Before Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Bayer 61
Not applicableLooking for participantsNCT05753839
What this trial is testing

The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Trial

Who this might be right for
Kidney CancerClear Cell Renal Cell Carcinoma MetastaticSynchronous Neoplasm
Yonsei University 40
Testing effectiveness (Phase 2)UnknownNCT00717587
What this trial is testing

Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer

Who this might be right for
Kidney Cancer
Abramson Cancer Center at Penn Medicine 20
Not applicableStudy completedNCT01107509
What this trial is testing

Pilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of Biomarkers

Who this might be right for
Carcinoma, Renal Cell
St. Joseph's Healthcare Hamilton 20
Not applicableLooking for participantsNCT03977571
What this trial is testing

Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial

Who this might be right for
Kidney CancerRenal Cell Carcinoma MetastaticSynchronous Neoplasm
Niels Fristrup 400
Early research (Phase 1)WithdrawnNCT03189186
What this trial is testing

Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas

Who this might be right for
Renal Cell CarcinomaMetastatic Kidney Cancer
University of California, Irvine
Not applicableStudy completedNCT01404104
What this trial is testing

Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
St. Joseph's Healthcare Hamilton 11
Not applicableNot Yet RecruitingNCT05941169
What this trial is testing

Primary Metastatic Renal Cell Carcinoma Treated With Immunecheckpoint Inhibitors and Cytoreductive Nephrectomy

Who this might be right for
Renal Cell Carcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 750
Testing effectiveness (Phase 2)Ended earlyNCT04370509
What this trial is testing

Pembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing Surgery

Who this might be right for
Metastatic Clear Cell Renal Cell CarcinomaRecurrent Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+2 more
University of California, San Francisco 6
Large-scale testing (Phase 3)Ended earlyNCT02535351
What this trial is testing

Targeted Therapy With or Without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers Discovery

Who this might be right for
Clear-cell Metastatic Renal Cell Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 13
Testing effectiveness (Phase 2)Ended earlyNCT06377722
What this trial is testing

Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer

Who this might be right for
Renal Cell Carcinoma MetastaticRenal Cell Carcinoma Stage IVRenal Cell Carcinoma Stage III
Fundacion Oncosur 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT00715442
What this trial is testing

Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma
M.D. Anderson Cancer Center 50
Large-scale testing (Phase 3)Looking for participantsNCT04510597
What this trial is testing

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Who this might be right for
Metastatic Clear Cell Renal Cell CarcinomaMetastatic Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
SWOG Cancer Research Network 364
Very early researchActive Not RecruitingNCT02210117
What this trial is testing

Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Kidney CarcinomaStage IV Renal Cell Cancer AJCC v7
M.D. Anderson Cancer Center 104
Testing effectiveness (Phase 2)Study completedNCT00480389
What this trial is testing

Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal

Who this might be right for
Renal Cell CarcinomaMetastatic Disease
University Health Network, Toronto 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07776717
What this trial is testing

TACTIC-RCC: Toripalimab Plus Axitinib Induction With Selective Deferred Cytoreductive Nephrectomy in TLS-Positive Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell CarcinomaAdvanced Clear Cell Renal Cell Carcinoma
Fudan University 30
Next Page